1Levine AB, Teppa J, McGough B, et al. Evaluation of the prethrombotic stage in pregnancy and in women using oral contraceptives [ J ]. Contraception, 1997,55 (1) : 53.
3FRANCO R F,REITSMA P H.Genetic risk factors ofvenous thrombosis[J].Hum Genet,2001,109(4):369-384.
4BARCZYK A,PIERZCHALA W.Risk factors of venous thromboembolism[J].Wiad Lek,2001,54(5-6):311-324.
5LEVINE A B,TEPPA J,McGOUGH B,et al.Evaluation of the prethrombotic stae in pregnancy and in women using oral contraceptives[J].Contraception,1997,55(1):53.
6GRUBER U F,DUCKERT F,FRIDRICH R,et al.Prevention of postoperative thromboembolism by dextran 40,low doses of heparin,orxantinolnicotinate[J].Lancet,1997,1:210.
7[1]Svensson PJ,Dahlback B.Resistance to activated protein C as a basis for venous thrombosis [J].N Engl J Med,1994,330:517-22.
8[2]Dahlback B.Inherited thrombophilia:resistance to activated protein C as a pathogenic factor of venous thromboembolism[J].Blood,1995,85:607-14.
9[3]Conard J,Horellou MH,Van Dreden P,et al.Thrombosis and pregnancy in congenital deficiencies in ATⅢ,protein C or protein S:study of 78 women[J].Thromb Haemost 1990,63:319-20.
10[4]Ginsberg JS,Turpie AGG.Thromboembolism and pregnancy[J].Inter Angiol,2001,20:103-9.
